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Abstract: Since the introduction of recombinant protein expression in the second half of the 1970s,
the growth of the biopharmaceutical field has been rapid and protein therapeutics has come to
the foreground. Biophysical and structural characterisation of recombinant proteins is the essential
prerequisite for their successful development and commercialisation as therapeutics. Despite the
challenges, including low protein solubility and inclusion body formation, prokaryotic host systems
and particularly Escherichia coli, remain the system of choice for the initial attempt of production
of previously unexpressed proteins. Several different approaches have been adopted, including
optimisation of growth conditions, expression in the periplasmic space of the bacterial host or
co-expression of molecular chaperones, to assist correct protein folding. A very commonly employed
approach is also the use of protein fusion tags that enhance protein solubility. Here, a range of
experimentally tested peptide tags, which present specific advantages compared to protein fusion
tags and the concluding remarks of these experiments are reviewed. Finally, a concept to design
solubility-enhancing peptide tags based on a protein’s pI is suggested.
Keywords: protein solubility; peptide tag; protein fusion tag; polycationic; polyanionic; recombinant
protein expression
1. Introduction
Since the first successful attempt at recombinant production of the human peptide hormone
Somatostatin in Escherichia coli in 1976 [1], protein therapeutics have come a long way. Until then,
small amounts of proteins and enzymes had to be extracted and purified from large amounts of
animal or plant tissues, or from biological fluids. However, the revolution that came along with the
recombinant production of proteins, enabling large-scale production of biological macromolecules,
allowed commercial success in the biopharmaceutical industry [2].
The biochemical characterisation of proteins is of utmost significance and a prerequisite prior to
their commercialisation. This process requires sufficient amounts of protein, which can be generated
with the use of recombinant technology. Protein stability, three-dimensional structure in order to
identify active sites, binding affinity for ligands or determination of their interaction are some of
the features that are useful in protein characterisation. In addition, from a regulatory point of view,
post-translational modifications, protein structure and propensity to aggregate have to be defined in
the development process of biosimilars [3].
Many different host systems have been exploited for recombinant protein production, including
various prokaryotic systems, yeast, insect, plant and mammalian cells [4]. Although prokaryotic
systems lack the mechanisms for complex post-translational protein modification, such as glycosylation,
and expression of complex protein folds involving disulphide bond formation can be challenging in
these systems [5], they have certain characteristics that frequently make them the host system of choice
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for first-time protein production. In particular, E. coli is characterised by rapid growth at a low cost,
with a cell doubling time of approximately 20 min [6]. This fast growth rate, in combination with the
range of plasmids and safe, compatible strains that can be exploited, which can be flexibly tailored to
the individual needs of recombinant production, makes this organism the ideal host [7].
2. Inclusion Bodies and Their Avoidance
Despite the clear advantages, recombinant expression of proteins in E. coli does not always
guarantee success and is not obstacle-free, as there is not a single protocol that can be followed in
order to avoid undesirable events. Insufficient yields, proteolytic degradation, protein misfolding,
formation of inclusion bodies, as well as lack of protein or enzyme activity, are only a few of the
possible unwanted outcomes [2].
Previously thought to be the result of unspecific hydrophobic interactions among intermediate,
partially folded, products of protein expression [8,9], inclusion bodies are now recognised as ordered,
dynamic structures, the organisation of which depends on specific interactions. In particular, Fourier
transform infrared microspectroscopy has revealed the presence of residual, native-like secondary
structures and intermolecular β-sheet structures in bacterial inclusion bodies, which resemble the
organisation of amyloid fibrils—see Figure 1 [10–12]. It has also been suggested that inclusion body
formation can be caused by self-association of correctly folded protein of low solubility or unfolded
protein molecules of mature protein [13]. In any case, the formation of inclusion bodies can represent
a major drawback during heterologous or homologous proteins’ overexpression in bacterial host
systems. This process is affected by and can be tuned with factors such as the environmental conditions
(e.g., temperature, pH and ionic strength of culture medium), as well as the amino acid sequence of
the protein [14] but can also be initiated by high protein concentration or inability of disulphide bonds
to form in the reducing environment of the cytoplasmic space of the bacterial cells [13].
It should also be noted however, that more recently, formation of inclusion bodies has been seen
as a potentially exploitable phenomenon, which has resulted in the development of strategies designed
to enhance inclusion body formation, such as the addition of aggregation-prone tags or pull-down
peptides [15,16]. Additionally, in some cases, the formation of inclusion bodies can facilitate protein
purification. There are methods in place that allow the successful refolding of proteins from inclusion
bodies, retaining their functionality [17]. However, the refolding process is not only time-consuming,
but can also be problematic, yielding aggregated and/or inactive protein [18].
As Hippocrates taught, “prevention is better than cure.” Thus, various approaches aimed at
preventing the formation of inclusion bodies, where undesirable, have been developed; these include
optimisation of the growth conditions which lower the rate of protein expression and allow sufficient
time for protein folding [19] and co-expression of molecular chaperones which mediate the correct
folding of proteins [20,21].
Additionally, expression in the periplasmic space, where disulphide bonds can be formed in the
presence of an oxidising environment [22], or mutations introduced in the reducing enzymes of the
cytoplasmic space, which render them inactive and allow disulphide bond formation [23], have been
exploited in order to overcome inclusion body formation. However, the most common approach is the
fusion of the target protein with protein or peptide tags, which are known to enhance solubility [24].
One of the suggested mechanisms for the solubilisation effect is the increase of the net protein charge,
which introduces repulsive electrostatic forces among protein molecules and promotes interaction
with the solvent molecules [25,26].
A combination of the periplasmic expression approach with the addition of a peptide tag in the
protein construct has been successfully used by our group in order to express a heterologous adhesin
from Helicobacter pylori in E. coli [27].
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Although their mechanism of action has not been fully elucidated, protein fusion tags are very 
commonly used in order to enhance the solubility of recombinantly expressed proteins in E. coli [28]. 
One of the very first protein fusion tags used was a heterologous protein, glutathione S-transferase 
(GST), from the trematode Schistosoma japonicum, which has been employed for the production and 
purification of numerous proteins of mammalian origin in E. coli [29]. 
Another protein, thioredoxin (Trx), is thermally stable and can be overexpressed, retaining its 
solubility even at high concentrations. It has been employed in order to enhance the solubility and 
facilitate the expression of many mammalian cytokines and growth factors, previously contained in 
inclusion bodies. Attempts to explain how the fusion protein is resistant to forming inclusion bodies 
suggest that the highly soluble thioredoxin does not aggregate and allows time for correct folding of 
the fusion protein, among other reasons [30]. 
Maltose-binding protein (MBP), 42.5 kDa, a homologous E. coli protein used as a solubility- 
enhancing tag [31], is significantly larger than GST (26 kDa) and Trx (11.7 kDa)—see Table 1; 
however, out of the three, MBP demonstrated the biggest solubilisation effect, as well as 
chaperone-like behaviour [32]. 
Figure 1. Suggested mechanism of native protein folding and association of intermediate, partially
folded protein molecules, bearing native-like secondary structures, leading to inclusion body formation.
3. Protein Fusion Tags
Although their mechanism of action has en fully elucidated, protein fusion tags a e very
commonly used in order to enhance the sol f recombinantly expr ssed proteins in E. coli [28].
One of the very first protein fusion tags used as a heterologous protein, glutathione S-transferase
(GST), from the trematode Schistosoma japonicum, which has been employed for the production and
purification of numerous proteins of mammalian origin in E. coli [29].
Another protein, thioredoxin (Trx), is thermally stable and can be overexpressed, retaining its
solubility even at high concentrations. It has been employed in order to enhance the solubility and
facilitate the expression of many mammalian cytokines and growth factors, previously contained in
inclusion bodies. Attempts to explain how the fusion protein is resistant to forming inclusion bodies
suggest that the highly soluble thioredoxin does not aggregate and allows time for correct folding of
the fusion protein, among other reasons [30].
Maltose-binding protein (MBP), 42.5 kDa, a homologous E. coli protein used as a solubility- enhancing
tag [31], is significantly larger than GST (26 kDa) and Trx (11.7 kDa)—see Table 1; however, out of the
three, MBP demonstrated the biggest solubilisation effect, as well as chaperone-like behaviour [32].
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Table 1. Protein fusion tags for solubility enhancement during recombinant protein production.
Name Full Name Size (kDa) Reference
GST Glutathione-S-transferase 26 Smith et al., 1988 [29]
MBP Maltose-binding protein 42.5 Maina et al., 1988 [31]
UB Ubiquitin ~9 Butt et al., 1989 [33]
Trx Thioredoxin 11.7 LaVallie et al., 1993 [30]
Z-tag/ZZ-tag IgG-binding domain from protein A 15.5/31 Samuelsson et al., 1994 [34]
GB1 Immunoglobulin-binding domain of protein G 6.2 Huth et al., 1997 [35]
DsbA Disulphide isomerase I 21.1 Collins-Racie et al., 1998 [36]
DsbAmut Zhang et al., 1998 [37]
NusA N-utilization substance A 55 Davis et al., 1999 [38]
IF2 domain I (or InfB(1-471) Initiation factor 2 Sorensen et al., 2003 [39]
CaBP Calcium binding protein Reddi et al., 2002 [40]
SUMO Small ubiquitin-related modifier 31 Malakhov et al., 2004 [41]
FTN-H Ferritin heavy-chain Ahn et al., 2005 [42]
Skp Seventeen kilodalton protein 17 Chatterjee et al., 2006 [43]
T7PK T7 protein kinase 4.5 Chatterjee et al., 2006 [43]
Ecotin E. coli trypsin inhibitor 16 Malik et al., 2006 [44]
RpoA RNA Polymerase α-subunit 39.5 Ahn et al., 2007 [45]
PotD Spermidine/putrescine-binding periplasmic protein 39.8 Han et al., 2007 [46]
Crr Glucose-specific phosphotransferase (PTS) enzyme IIA component 20 Han et al., 2007 [46]
Tsf Elongation factor Ts 30.6 Han et al., 2007 [47]
SlyD Aggregation-resistant protein 22.2 Han et al., 2007 [48]
msyB Acidic protein 14 Su et al., 2007 [49]
RpoS RNA polymerase sigma factor 39 Park et al., 2008 [50]
yjgD 15 Zou et al., 2008 [51]
rpoD σ 70 factor of RNA polymerase 20 Zou et al., 2008 [51]
HaloTag7 Inactive derivative of DhaA, a bacterial haloalkane dehalogenase 34 Ohana et al., 2009 [52]
sfGFP Superfolder green fluorescent protein Wu et al., 2009 [53]
Mocr Monomeric bacteriophage T7 0.3 16.7 DelProposto et al., 2009 [54]
SNUT Solubility eNhancing Ubiquitous Tag 19 Caswell et al., 2010 [55]
EspA E. coli secreted protein A 25 Cheng et al., 2010 [56]
ArsC Arsenate reductase 16 Song et al., 2011 [57]
BLA AmpC-type β-lactamase Tokunaga et al., 2010 [58]
InfB1-21 Entity of InfB(1-471) responsible for increased expression 28 Hansted et al., 2011 [59]
Fh8 Fasciola hepatica antigen 8 Costa et al., 2014 [28]
SmbP Small metal-binding protein 9.9 Vargas-Cortez et al., 2016 [60]
Ffu β-fructofuranosidase truncations 17.7–29.5 Cheng et al., 2017 [61]
TDX Tetracopeptide domain-containing thioredoxin 35 Xiao et al., 2018 [62]
HE-MBP(Pyr) Truncated maltotriose-binding protein with modified histidine tag Han et al., 2018 [63]
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Also, derived from yeast, a small ubiquitin-related modifier, or SUMO, has been found to have
an even better solubilising effect than MBP [64]. Although its mechanism of enhancing solubility
is currently unclear, it is speculated that it might act as a chaperone, similarly to Ubiquitin [65].
Alternatively, it might function as a nucleation point for the correct folding of the fusion protein [64].
In contrast to the above, it has also been reported that the introduction of MBP and Trx
in the C-terminus of the mammalian proteinase procathepsin D did not prevent inclusion body
formation but facilitated the recovery of soluble, yet not active, protein following refolding [66]. A few
hypotheses regarding the solubility-enhancing mechanisms of protein fusion tags are described in [65].
These include the conformation of the fusion proteins into micelle-like structures, the attraction of
chaperones or an intrinsic chaperone-like activity in the fusion proteins and the presence of electrostatic
repulsive forces due to the protein’s net charge.
The solubilising effect of the protein tags seems to rely on the tags’ correct folding. However,
due to their large size, their three-dimensional conformation can potentially interfere with the structure
and most significantly with the activity of the expressed protein [67]. Thus, proteolytic removal of these
tags after expression and purification of the fusion protein is common practice; however, the target
protein’s solubility after tag removal cannot be predicted and the tag removal process might exert
negative effects on the quality of the protein, such as product heterogeneity due to proteolytic cleavage
at multiple sites, precipitation or poor recovery [24].
Although in most cases the removal of a big protein fusion tag is desired, there have been cases
where the presence of the MBP has not proven an obstacle for the resolution of a crystal structure
due to conformational heterogeneity attributed to the flexible linkage between the protein tag and
the target protein [68]. In fact, techniques such as surface mutagenesis of MBP, in order to decrease
entropy [69], or careful design of the linker between the MBP and the target protein [70], have been
employed in order to facilitate crystallisation of the fusion protein.
4. Peptide Tags
As an alternative, small peptide tags have been used as solubility-enhancing tags, almost as
early as protein fusion tags [71]. These peptide tags are relatively short, usually no longer than fifteen
residues and comprise mostly one or two amino acids—repeated a varying number of times. They are
polar and bear a positive or negative overall charge. Due to their small size and their repetitive amino
acid content, they do not necessarily have an ordered three-dimensional conformation and are usually
not resolved in protein crystal structures. This was the case for a hexalysine tag which was not defined
in the crystal structure of the Helicobacter pylori adhesin BabA [72] or the ten different tags which
were mostly invisible in [73]. As a result, they can exert their solubility-enhancing effect without
interfering with the structure of the protein of interest or compromising its activity [67]. Additionally,
an extra step for the removal of the peptide tags after production and/or purification is not necessarily
required, in contrast to the case of protein fusion tags [24]. Finally, the expression of a large fusion
protein tag instead of a short peptide tag is more demanding and acts as a metabolic burden on the
bacterial hosts [25].
4.1. Polycationic Tags as Enhancers of Protein Solubility in Recombinant Protein Production
Since the first reference of a polylysine tag as a protein solubilising peptide tag in 1994 [71],
many studies (reviewed here) have investigated the effect of different peptide tags on protein
expression and solubility, without affecting the proteins’ function and activity. In this original study,
a formerly chemically synthesised protein of low solubility, the minibody [74], was instead expressed
in E. coli with a 3-lysine tag incorporated in either the N- or the C-terminus. As a result, the aqueous
solubility of the tagged protein was increased by a 100-fold [71].
The introduction of two positively charged lysine residues in the N-terminus of the enzyme
HemA [75] or of a hexalysine tag in the C-terminus of the protein BabA [27] led to the protection of the
proteins against proteolytic degradation. Possible explanations for this stabilisation effect could be
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either the interference of the positively charged lysine residues preventing the binding of the proteases,
or the correct folding of the tagged proteins [75]; a few proteases, such as DegP and Tsp, are known to
show preference for mis- or unfolded target proteins, respectively. The hexalysine tag also seemed to
strongly enhance the solubility of the recombinantly expressed BabA protein [27].
A slightly different solubilising tag, comprising glycine as well as lysine residues, proved to
improve the solubility of the hydrophobic virus protein “u” (Vpu) from HIV-1, allowing its HPLC
purification and 2D-NMR analysis in solution [76].
Other positively charged peptide tags were analysed for their effect on protein solubility,
consisting of the basic amino acids arginine or histidine [25,67,77–82]. A comparison between arginine
and lysine tags, from one to five residues long, in the N- or C-terminus of the poorly soluble bovine
pancreatic trypsin inhibitor, revealed that the higher charges of the longer peptides had a bigger
solubilising effect. Also, the position of the tag seemed to have an effect in this case, as the tags
introduced to the C-terminus enhanced solubility more than the tags in the N-terminus of the protein.
Finally, the arginine tags were more effective than the lysine tags of the same size in improving
solubility, potentially due to the more hydrophilic character of arginine. The enhancement of the
solubility was attributed to the repulsive electrostatic interactions between similarly charged tags,
which prevent aggregation and allow sufficient time for correct folding, rather than their function as
folding nuclei, which might have required a certain position in the expression construct [67].
Similar findings were obtained when positively charged arginine or lysine tags, comprising ten
residues, were introduced into the enzyme Candida antarctica lipase B (CalB). The presence of these
tags resulted in the transfer of the majority of the expressed protein from the insoluble to the soluble
protein fraction in the cells, without affecting the protein expression yield overall [25].
As far as arginine tags are concerned, the introduction of a polyarginine tag in the C-terminus of
the protein β-urogastrone, which led to the increase of the isoelectric point of the protein, has been used
in order to facilitate the purification of the protein by cation exchange chromatography, which requires
solubility in an aqueous system [77]. Recently, a C-terminal peptide tag rich in arginine was also
exploited for the improved expression and enhanced solubility of the poorly soluble Tobacco Etch
Virus (TEV) protease [78].
Histidine is the least basic amino acid out of the three, based on the pKa values of their side
chains; 6.04 compared to 10.54 and 12.48 for lysine and arginine, respectively. Since the affinity of
histidine-rich proteins for metal-ion resins was observed [83,84], hexahistidine tag has been established
as one of the most popular affinity purification tags. The small size, the N- or C-terminal position
that prevents interference with the function of the protein [85] and the highly selective interaction
of histidine residues with nickel-NTA [86] are a few of the reasons that render the histidine tag so
widely used in protein purification. However, when its effect on protein solubility was tested, it was
found to be negative, resulting in lower protein solubility. In particular, the negative impact on protein
solubility was stronger when the tag was found in the C-terminus, rather than the N-terminus, both in
recombinant protein production in E. coli [79] and in a cell-free expression system [80].
Also, the effect of the length of a polyhistidine tag on protein expression was investigated and it
was found that the longer decahistidine tag led to decreased expression yield of the protein aquaporin Z
compared to the hexahistidine tag, without affecting the solubilisation of the protein by detergents [81].
Finally, the hexahistidine-tagged proteins were compared against proteins fused with other commonly
used solubilising tags, such as GST and MBP and their relative solubility was found to be lower,
as expected based on previous findings [82].
Chaperonins, a class of molecular chaperones that enhance protein folding in an ATP-dependent
manner [87], have been found to interact with their substrate proteins based on the structural and
biochemical properties of the latter. Hence, they can be classified based on their hydrophobic or polar
interactions with protein substrates [88]. The molecular chaperonin CpkB from Thermococcus kodakarensis
belongs to the second class, as it has been found that the negatively charged C-terminus of the enzyme
facilitates its target protein recognition of positively charged proteins. The addition of a positively
Microorganisms 2018, 6, 47 7 of 17
charged tag to the target protein (see Table 2) can lead to enhanced specificity of the negatively charged
chaperonin for the target protein, mediated by attractive electrostatic interactions; this results in
protection of the protein against thermal denaturation and appropriate folding [89].
It has also been reported in the literature that the activity of the chaperone Hsp90 to prevent
aggregation and enhance correct protein folding entirely depends on two acidic regions, bearing
negative charge; upon deletion of this charge, the anti-aggregation activity is compromised [90].
4.2. Solubilising Peptide Tags in Solid-Phase Peptide Synthesis (SPPS) and Native Chemical Ligation
The solubility enhancement effect of a polycationic tag has also been investigated in the fields of
SPPS and native chemical ligation. A polycationic tag, rich in but not entirely consisting of arginine,
introduced in both the N- and C-termini of poorly soluble peptides synthesised by Boc or Fmoc SPPS,
rendered them soluble in water and allowed their purification in an aqueous environment [91–93].
The same effect and improved purification was observed after the addition of a pentalysine tag in
the C-terminus of the poorly soluble A-chain of insulin glargine [94]. In all of the above examples,
the solubilising tag was removed post purification.
In the case of native chemical ligation, which is a chemoselective reaction between an unprotected
peptide with a C-terminal thioester modification and an also unprotected peptide with an N-terminal
cysteine for the generation of native proteins [95], polyarginine tags, carrying positive charges, have been
used. They have been shown to enhance the solubility of the peptide components of the membrane
opioid receptor-like 1 [96] and the human immunodeficiency virus type 1 protease enzyme [97].
4.3. Polyanionic Tags as Enhancers of Protein Solubility in Recombinant Protein Production
Although so far positively charged polycationic tags which mostly enhance protein solubility
have been reviewed, the opposite phenomenon has also been observed; polyanionic amino acid tags
have been shown to enhance protein solubility too [98,99]. The addition of a negatively charged
9-aspartic acid tag led to increased solubility and expression of Gaussia luciferase in the soluble protein
fraction [98]. Also, the presence of a polyaspartate tag resulted in increased protein expression and
extracellular secretion of the periplasmic enzyme Asparaginase isozyme II [99].
Additions of single negatively charged residues, as well as longer sequences carrying negative
net charge, were considered for their contribution to protein solubility of proteins prone to
aggregation [100]. As with polycationic tags, the repulsive electrostatic interactions caused by the
negative charge of the peptide tag seemed to enhance solubility and facilitate correct protein folding,
by delaying protein aggregation, irrespectively of the size and structural conformation of the peptide
tag [100]. Also, compared to commonly used solubility-enhancing fusion tags, such as MBP and Trx,
peptide tags with high acidic content were found to enhance protein solubility to a greater extent [51].
4.4. Polycationic versus Polyanionic Tags
A few studies have compared homogeneous 5-amino acid long peptide tags comprising ten
different amino acids with distinct biophysical properties (basic, acidic, polar and hydrophobic),
side by side [73,101,102]. The overall conclusion of these studies was that the pentalysine tag had
the biggest solubilisation effect, although the majority of the tags seemed to enhance solubility to
a greater or lesser extent, excluding proline and isoleucine tags. It was revealed that although the
positively charged peptide tags consisting of lysine or arginine led to increased solubility of bovine
pancreatic trypsin inhibitor at two different pH values, 4.7 and 7.7, the acidic tags consisting of aspartic
or glutamic acid, only improved solubility at pH 7.7, where their side chains were in their ionised
state [73,101]. Also, from all of the aforementioned peptide tags, only the protein bearing a pentalysine
tag was brought to high concentrations without reaching supersaturation and remained stable and
aggregate-free at both pH values for up to two days [102].
A comprehensive list of polar, charged or neutral, peptide tags, which have been assessed and
found to have a solubilisation effect on proteins that they are fused to, is presented in Table 2.
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Following up on the observation that the majority of the signal peptides in the N-terminus of
bacterial periplasmic proteins comprise basic amino acid residues, it was found that the presence
of positive charges in the N-terminus is not essential for protein secretion [103]. To the contrary,
when peptide tags with different biophysical properties were tested for their effect on protein
expression and secretion of CalB, it was found that positively charged polylysine tags even hindered
expression, while the negatively charged tags enhanced protein expression and secretion [104].
It has also been found that the presence of two arginine residues, bearing a positive charge,
in the signal sequence of the mature protein alkaline phosphatase, restricted the secretion from the
cytoplasmic to the periplasmic space; this could be either due to alteration of protein conformation
or blockage of the secretion machinery when the positively charged N-terminus approaches the
negatively charged phospholipids of the membrane [105]. Similarly, the presence of negative charge
in the N-terminus leads to protein accumulation in the cytoplasm and delays protein secretion [103].
However, it has also been reported that this outcome can be reversed with the addition of a positively
charged residue in the hydrophobic signal peptide [106].
Table 2. Polyionic or polar peptide tags assessed for their solubility enhancement effect during
recombinant protein expression.
Name pI Size (kDa) Reference
Polycationic tags
(Arg)1–5 10.00–12.62 0.174–0.799 Kato et al., 2007 [67]
(Arg)5
(His)5
12.62
7.66
0.799
0.704
Islam et al., 2015 [73]
Islam et al., 2012 [101]
Khan et al., 2015 [102]
(Arg)10 12.95 1.6
Jung H-J et al., 2011 [25]
Johnson et al., 2007 [97]
(Arg-Gly-Gly)3-Gly 12.30 0.886 Englebretsen et al., 1999 [92]
Poly(Arg) Smith et al., 1984 [77]
(Gly-Arg)3-(Arg)3 12.91 1.5 Kalpana et al., 2018 [78]
(Gly-Arg)4 12.48 0.871 Englebretsen et al., 1996 [91]
Gly-(Arg)5 12.62 0.856 Sato et al., 2005 [96]
Gly(Arg-Gly-Gly)3
Gly(Lys-Gly)6
12.30
10.70
0.886
1.2 Choma et al., 1998 [93]
(Gly)2-(Arg)2-Gly-Arg
Gly-Lys-Gly-(Lys)2
12.30
10.28
0.658
0.517 Gao et al., 2017
(Gly)2(Lys)4 10.47 0.645 Park et al., 2003 [76]
(Lys)1–5 8.88–10.61 0.146–0.659 Kato et al., 2007 [67]
(Lys)2 10.00 0.274 Wang et al., 1999 [75]
(Lys)3 10.28 0.402 Bianchi et al., 1994 [71]
(Lys)5 10.61 0.659
Islam et al., 2015 [73]
Hossain et al., 2009 [94]
Islam et al., 2012 [101]
Khan et al., 2015 [102]
(Lys)6 10.70 0.787 Hage et al., 2015 [27]
(Lys)10 10.94 1.3 Englebretsen et al., 1999 [92]
Polyanionic tags
(Asp)5 3.34 0.593
Kim et al., 2015 [99]
Kim et al., 2014 [104]
(Asp)5 Islam et al., 2015 [73]
(Glu)5 3.34 0.664
Islam et al., 2012 [101]
Khan et al., 2015 [102]
[Gly-(Asp)3]3 3.16 1.2 Rathnayaka et al., 2011 [98]
Negative peptide extensions (>−6) Zhang et al., 2004 [100]
Polar tags
(Asn)5
(Gln)5
(Ser)5
5.50
5.50
5.50
0.588
0.659
0.453
Islam et al., 2015 [73]
Islam et al., 2012 [101]
Khan et al., 2015 [102]
It is worth mentioning that homogeneous polyionic tags, both positively and negatively charged,
have been exploited in different applications in research. These include matrix-assisted refolding from
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inclusion bodies and protein purification, both mediated by the reversible immobilisation of tagged
protein on an ion-exchange resin [107]. An example is the use of a polyanionic peptide tag consisting
of varying number of glutamic acid residues for the purification of the polyoma coat proteinVP1 with
anion-exchange chromatography [108].
This immobilisation feature can also facilitate the functionalisation of flat surfaces, by immobilising
protein molecules on the surface in a specific and consistent orientation. Last but not least, the generation
of chimeric bifunctional proteins, through the electrostatic attraction of two proteins with oppositely
charged tags has been described; due to poor stability, however, the introduction of cysteine
residues has also been studied for the formation of more stable, covalent disulphide bonds [107].
In particular, polyionic peptides have been exploited for the heterodimerisation of α-glucosidase
fused with a 10-arginine tag and a modified Fab fragment fused with a 10-glutamic acid tag, both
enhanced with a cysteine residue. The chimeric product retained both the enzymatic activity and
antigen-binding capacity [109].
4.5. Polyionic Tags Displaying the Opposite Effect
It has also been reported in the literature that the presence of a hexalysine tag has led to
recombinant protein production in inclusion bodies, due to the intramolecular attractive electrostatic
interactions between the positively charged polylysine tag and the negatively charged protein at the
intracellular pH 7.0 [26].
In addition, polypeptides comprising either lysine or glutamic acid residues have been exploited
for the reversible precipitation of a range of proteins in low ionic strength solutions, which were
then redissolved at physiological ionic strength (150 mM NaCl). Negatively charged proteins were
precipitated by mixing with polylysine peptides and positively charged proteins were precipitated by
mixing with polyglutamic acid peptides. The cause of precipitation is the intermolecular attractive
electrostatic interactions between the proteins and the free peptides [110].
5. Supercharging of Proteins
Based on all of the aforementioned, it is also important to consider the effect of the overall protein
charge on solubility, not found localised in one of the two termini but spread across the protein
sequence and surface. So, although it is known that proteins are least soluble at their isoelectric
points where they do not bear any net positive or negative charge, it was desired to prove that
protein charges prevent aggregation [111]. The mutation of positively charged arginine residues of
eukaryotic proteins expressed in E. coli to negatively charged aspartate residues resulted in enhanced
protein solubility [37]. Increased solubility was also observed following mutation of residues of green
fluorescent protein exposed to the solvent to positively or negatively charged residues, leading to
highly charged protein molecules [111].
This process, called supercharging, prevented both thermally and chemically induced protein
aggregation [111]. The same effect of enhanced solubility and stability was also observed after
supercharging a human enteropeptidase; it was speculated that a small increase in the protein’s
net charge by supercharging the protein resulted in more significant increase in protein solubility
than the solubility enhancement conveyed by peptide tags [112]. Nonetheless, the point mutations
involved in the supercharging of protein surfaces could result in loss of protein activity and/or alter
its biochemical properties [73].
6. Discussion
As explained above, there are several factors that can render a protein insoluble or lead to
the formation of inclusion bodies during recombinant protein production; not only high protein
concentrations can result in aggregation but also large proteins are more prone to it. Of course,
the composition of a protein in its primary amino acid sequence is crucial for its propensity to
aggregate, as long hydrophobic regions will make the protein less soluble [113].
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On the other hand, protein net average charge, as well as hydrophilicity, are known to be related
to protein solubility [114]. The average charge of a protein at a certain pH value depends on the pI,
which can be calculated from the pKa values of the side chains of the residues that are ionised. Due to
protein folding, the experimental pKa values, hence the pI of the protein, can be slightly different from
the calculated value. As mentioned earlier, proteins are the least soluble at their pIs and their solubility
increases at differing pH values [115].
Thus, the introduction of net charge by the addition of even a single amino acid residue can
enhance solubility by introducing repulsive electrostatic interactions between protein molecules that
allow sufficient time for the correct folding of proteins, or by disrupting hydrophobic interactions
between or within the same protein molecule [25]. Such peptide tags amplify the solubility properties
of the amino acids regardless of their position in the N- or C-terminus of the protein, which offers
the advantage of flexibility [66]. Another advantage of peptide tags over protein fusion tags is that
in order to exert their solubilisation effect, an ordered secondary structure is not required, as is the
case for the protein fusion tags, in the cases when they potentially function as a folding nucleus [101].
The above rationale has been summarised in Figure 2.
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peptide tags are more versatile and smaller in size, which means their removal is not always essential,
they do not pose a burden on the host system’s metabolism and they do not affect the target protein’s
structure or function.
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A method, based on highly conserved amino acid sequences in a range of soluble proteins,
has been described for the design of novel solubility-enhancing peptide tags [116]. It is suggested that
the solubility of a protein can be theoretically calculated and controlled. However, it is acknowledged
that there always needs to be compatibility between the protein of interest and the solubility controlling
peptide tag [116].
7. Conclusions
From all the above, it becomes obvious that the choice of the most appropriate solubility-enhancing
tag depends on the individual protein and requires careful design; generalisation should be
avoided [64]. Peptide tags have overall benefits compared to the protein fusion tags, due to their small
size and versatility [73]. It is speculated that the introduction of a peptide tag bearing similar charge as
the protein of interest at a certain pH value in either of the protein’s termini will enhance solubility due
to inter- and intramolecular repulsive interactions. Peptide tags of the opposite charge to the protein
of interest should be avoided, as they could lead to protein precipitation instead.
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